All In MedTech

FDA Clearance Tracker · P000055

UBIS 5000 BONE SONOMETER

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 21, 2026Latest source record: Jul 17, 2001 (this decision)Source: openFDAMethods & limitations

PMA

The decision

FDA number
P000055
Device name
UBIS 5000 BONE SONOMETER
Applicant location
Perols
Received
Dec 18, 2000
Decided
Jul 17, 2001
Decision
Approved (reclassified)

Device type

Device class
Class II
Regulation
21 CFR 892.1180

Every decision under product code MUA

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE UBIS 5000. THE UBIS 5000 IS A QUANTITATIVE ULTRASOUND (AUS) BONE SONOMETER AND IS INDICATED FOR THE MEASUREMENT OF BROADBAND ULTRASOUND ATTENUATION (BUA) OF THE CALCANEUS, AS AN AID TO DIAGNOSE OSTEOPOROSIS AND TO ESTIMATE THE RISK OF SUBSEQUENT ATRAUMATIC FRACTURE. THE OUTPUT IS EXPRESSED IN TERMS OF BOTH BUA AND T-SCORE.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code MUA. The earliest in FDA's data is P970017, decided Mar 12, 1998.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Diagnostic Medical Systems

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.